F. Bacci

Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients

Stefano Pileri, Stefano Ascani, Maria Christina Cox et al. · Leukemia · 2006 · 694 citations

Hematological Malignancy, Cytogenetic Analysis, Medicine +8

A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients

Pier Luigi Zinzani, Monica Tani, S. Fanti et al. · Annals of Oncology · 2008 · 86 citations · Full text

Lymphoid Neoplasia, Surgical Oncology, Phase Ii Trial +8

Primary liver neoplasms: Evaluation of proliferative index using MoAb Ki 67

Francesco Grigioni, Antonietta D’Errico, F. Bacci et al. · The Journal of Pathology · 1989 · 80 citations

Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer

Wainer Zoli, Luca Ricotti, M. Dal Susino et al. · British Journal of Cancer · 1999 · 54 citations · Full text

Loss of heterozygosity and K-ras gene mutations in gastric cancer

Guglielmina Nadia Ranzani, Beatrice Renault, Natalia S. Pellegata et al. · Human Genetics · 1993 · 51 citations

Somatic Variant, Gastrointestinal Oncology, Tumor Heterogeneity +9